4//SEC Filing
Keeney Adam 4
Accession 0001127602-25-013346
CIK 0000875045other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:19 PM ET
Size
8.3 KB
Accession
0001127602-25-013346
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Keeney Adam
Head of Corporate Development
Transactions
- Exercise/Conversion
Common Stock
2025-05-01+938→ 2,838 total - Exercise/Conversion
Restricted Stock Unit
2025-05-01−938→ 939 totalExercise: $0.00Exp: 2026-05-01→ Common Stock (938 underlying) - Tax Payment
Common Stock
2025-05-01$120.93/sh−454$54,902→ 2,384 total
Footnotes (1)
- [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of May 1, 2023.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001973607
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:19 PM ET
- Size
- 8.3 KB